Krempa David 4
4 · Eton Pharmaceuticals, Inc. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
Krempa David
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-12-12$17.00/sh−6,264$106,488→ 632,180 total - Award
Restricted Stock Units
2025-12-11+5,300→ 638,468 total→ Common Stock (5,300 underlying)
Footnotes (5)
- [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
- [F2]The shares were sold in multiple trades at prices ranging from $16.83 to $17.11. The price reported above reflects the weighted average sales price.
- [F3]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F4]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F5]The restricted stock units vest immediately as of the award date.